Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Sarcoma (STS)”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612098
What this trial is testing

Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 274
Not applicableLooking for participantsNCT07134192
What this trial is testing

Fluorescence-Guided Optimization of Sarcoma Margins

Who this might be right for
Soft Tissue Sarcoma of the Trunk and ExtremitiesSarcoma
University of Aarhus 90
Early research (Phase 1)Study completedNCT00276302
What this trial is testing

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
Infinity Pharmaceuticals, Inc. 63
Testing effectiveness (Phase 2)Study completedNCT05497843
What this trial is testing

Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

Who this might be right for
Soft Tissue Sarcoma
Chipscreen Biosciences, Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Study completedNCT00204646
What this trial is testing

Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)

Who this might be right for
Sarcoma, Soft Tissue
University Hospital Tuebingen
Testing effectiveness (Phase 2)Active Not RecruitingNCT05688280
What this trial is testing

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

Who this might be right for
Metastatic Solid TumorColon CancerNonsmall Cell Lung Cancer+1 more
Immunophotonics, Inc. 42
Early research (Phase 1)Ended earlyNCT05813327
What this trial is testing

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaStsSarcoma,Soft Tissue
Washington University School of Medicine 6
Not applicableLooking for participantsNCT05944913
What this trial is testing

Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy

Who this might be right for
Soft Tissue Sarcoma
Centre Leon Berard 166
Testing effectiveness (Phase 2)Study completedNCT00918489
What this trial is testing

Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)

Who this might be right for
Soft Tissue Sarcoma
Heidelberg University 40
Not applicableLooking for participantsNCT06967961
What this trial is testing

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Who this might be right for
Urothelial CarcinomaRenal CancerProstate Adenocarcinoma+7 more
Institut Claudius Regaud 450
Testing effectiveness (Phase 2)Looking for participantsNCT07460986
What this trial is testing

A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.

Who this might be right for
Soft Tissue Sarcoma (STS)
MedSIR 278
Not applicableUnknownNCT05739084
What this trial is testing

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS

Who this might be right for
Soft Tissue Sarcomas
Centre Leon Berard 300
Testing effectiveness (Phase 2)Study completedNCT04887298
What this trial is testing

Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases

Who this might be right for
Sarcoma,Soft TissuePulmonary Metastasis
Moleculin Biotech, Inc. 36
Large-scale testing (Phase 3)UnknownNCT02449343
What this trial is testing

Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)

Who this might be right for
Soft Tissue Sarcoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 233
Large-scale testing (Phase 3)Looking for participantsNCT05597917
What this trial is testing

TTF-NGR Randomized Study - STS

Who this might be right for
Soft Tissue Sarcoma
Universität Münster 126
Large-scale testing (Phase 3)Ended earlyNCT02929394
What this trial is testing

Trabectedin Maintenance Post 1st-line in STS

Who this might be right for
Sarcoma, Soft Tissue
European Organisation for Research and Treatment of Cancer - EORTC 13
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Testing effectiveness (Phase 2)Study completedNCT00484341
What this trial is testing

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

Who this might be right for
Metastatic Adult Soft Tissue Sarcoma
AGC Biologics S.p.A. 69
Early research (Phase 1)Looking for participantsNCT07261631
What this trial is testing

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast Cancer+3 more
Novartis Pharmaceuticals 180
Next Page